These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 24269728)

  • 1. Spinal but not cortical microglia acquire an atypical phenotype with high VEGF, galectin-3 and osteopontin, and blunted inflammatory responses in ALS rats.
    Nikodemova M; Small AL; Smith SM; Mitchell GS; Watters JJ
    Neurobiol Dis; 2014 Sep; 69():43-53. PubMed ID: 24269728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
    Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglia and motor neurons during disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis: changes in arginase1 and inducible nitric oxide synthase.
    Lewis KE; Rasmussen AL; Bennett W; King A; West AK; Chung RS; Chuah MI
    J Neuroinflammation; 2014 Mar; 11():55. PubMed ID: 24655927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-10 Controls Early Microglial Phenotypes and Disease Onset in ALS Caused by Misfolded Superoxide Dismutase 1.
    Gravel M; Béland LC; Soucy G; Abdelhamid E; Rahimian R; Gravel C; Kriz J
    J Neurosci; 2016 Jan; 36(3):1031-48. PubMed ID: 26791230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase.
    Gowing G; Philips T; Van Wijmeersch B; Audet JN; Dewil M; Van Den Bosch L; Billiau AD; Robberecht W; Julien JP
    J Neurosci; 2008 Oct; 28(41):10234-44. PubMed ID: 18842883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
    Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
    Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microglia RAGE exacerbates the progression of neurodegeneration within the SOD1
    MacLean M; Juranek J; Cuddapah S; López-Díez R; Ruiz HH; Hu J; Frye L; Li H; Gugger PF; Schmidt AM
    J Neuroinflammation; 2021 Jun; 18(1):139. PubMed ID: 34130712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
    Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
    Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive changes in microglia and macrophages in spinal cord and peripheral nerve in the transgenic rat model of amyotrophic lateral sclerosis.
    Graber DJ; Hickey WF; Harris BT
    J Neuroinflammation; 2010 Jan; 7():8. PubMed ID: 20109233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of thymic stimulation of CD4+ T cell expansion on disease onset and progression in mutant SOD1 mice.
    Sheean RK; Weston RH; Perera ND; D'Amico A; Nutt SL; Turner BJ
    J Neuroinflammation; 2015 Feb; 12():40. PubMed ID: 25889790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appearance of phagocytic microglia adjacent to motoneurons in spinal cord tissue from a presymptomatic transgenic rat model of amyotrophic lateral sclerosis.
    Sanagi T; Yuasa S; Nakamura Y; Suzuki E; Aoki M; Warita H; Itoyama Y; Uchino S; Kohsaka S; Ohsawa K
    J Neurosci Res; 2010 Sep; 88(12):2736-46. PubMed ID: 20648658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional differences in the inflammatory and heat shock response in glia: implications for ALS.
    Clarke BE; Gil RS; Yip J; Kalmar B; Greensmith L
    Cell Stress Chaperones; 2019 Sep; 24(5):857-870. PubMed ID: 31168740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microglial keratan sulfate epitope elicits in central nervous tissues of transgenic model mice and patients with amyotrophic lateral sclerosis.
    Foyez T; Takeda-Uchimura Y; Ishigaki S; Narentuya ; Zhang Z; Sobue G; Kadomatsu K; Uchimura K
    Am J Pathol; 2015 Nov; 185(11):3053-65. PubMed ID: 26362733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression.
    Apolloni S; Fabbrizio P; Amadio S; Volonté C
    J Neuroinflammation; 2016 Aug; 13(1):191. PubMed ID: 27549088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of methylene blue on microglia-induced inflammation and motor neuron degeneration in the SOD1(G93A) model for ALS.
    Dibaj P; Zschüntzsch J; Steffens H; Scheffel J; Göricke B; Weishaupt JH; Le Meur K; Kirchhoff F; Hanisch UK; Schomburg ED; Neusch C
    PLoS One; 2012; 7(8):e43963. PubMed ID: 22952827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ablation of interleukin-19 improves motor function in a mouse model of amyotrophic lateral sclerosis.
    Komiya H; Takeuchi H; Ogawa Y; Suzuki K; Ogasawara A; Takahashi K; Azuma YT; Doi H; Tanaka F
    Mol Brain; 2021 Apr; 14(1):74. PubMed ID: 33931083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spinal cord pathology is ameliorated by P2X7 antagonism in a SOD1-mutant mouse model of amyotrophic lateral sclerosis.
    Apolloni S; Amadio S; Parisi C; Matteucci A; Potenza RL; Armida M; Popoli P; D'Ambrosi N; Volonté C
    Dis Model Mech; 2014 Sep; 7(9):1101-9. PubMed ID: 25038061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ca
    Cocozza G; di Castro MA; Carbonari L; Grimaldi A; Antonangeli F; Garofalo S; Porzia A; Madonna M; Mainiero F; Santoni A; Grassi F; Wulff H; D'Alessandro G; Limatola C
    Brain Behav Immun; 2018 Oct; 73():584-595. PubMed ID: 29981425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
    Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.
    Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN
    J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.